Abstract
Bone marrow mesenchymal stem cells (BMSCs)-based therapy plays a pivotal role in the regeneration of damaged endometrium. Considerable studies have illustrated the therapeutic potential of BMSCs administration diversely. However, the homing, survival and differentiation potential of these differently administered cells are poorly defined. This study aims to compare the engraftment, retaining time and therapeutic efficiency between locally or intra-arterially administered BMSCs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
